The enormous opioid lawsuits across the nation are affecting pain science too.
Legal evidence is needed to pin addiction and death on opioid manufacturers, but the science suggests that a large and ready supply of legal prescription painkillers led to many addictions.
It seems that overall drug spending is still on the rise because of the skyrocketing price of new, brand-name drugs.
Out of public view, corporations are cutting deals that give consumers little choice but to buy brand-name drugs—and sometimes pay more at the pharmacy counter than they would for generics.
Drugmakers are increasingly agreeing to refund money if patients don't respond to medications as expected.
Endo Pharmaceuticals appears to be preparing its opposition to the FDA's request.
But the people won't, as the push for pharma reform mounts.
Big Pharma’s focus on blockbuster cancer drugs squeezes out research into potential treatments that are more affordable. Says one researcher: "What is scientific and sexy is driven by what can be monetized."